Phenotypical and molecular assessment of the virulence potential of KPC-3-producing Klebsiella pneumoniae ST392 clinical isolates.


Journal

Microbiological research
ISSN: 1618-0623
Titre abrégé: Microbiol Res
Pays: Germany
ID NLM: 9437794

Informations de publication

Date de publication:
Nov 2020
Historique:
received: 14 02 2020
revised: 28 06 2020
accepted: 03 07 2020
pubmed: 12 7 2020
medline: 25 5 2021
entrez: 12 7 2020
Statut: ppublish

Résumé

Klebsiella pneumoniae is a Gram-negative bacterium of clinical importance, due to its resistance to several antibiotic classes. We have identified 4 clinical isolates of K. pneumoniae sequence type (ST) 392 KPC-3-producing strains from patients at the Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione (IRCCS-ISMETT), a Southern Italian transplantation health facility, during a routine surveillance for carbapenemase-producing Enterobacterales from in-house clinical samples. Since those were among, to the best of our knowledge, the first KPC-producing K. pneumoniae ST392 isolated in Europe, we assessed their virulence potential, to understand if this particular ST can become an endemic clinical threat. ST392 isolates were investigated to assess their virulence potential, namely resistance to human sera, formation of abiotic biofilms, adhesion to biotic surfaces, exopolysaccharide production and in vivo pathogenesis in the wax moth Galleria mellonella animal model. ST392-belonging strains were highly resistant to human sera. These strains also have a high capacity to form abiotic biofilms and high levels of adhesion to the human epithelial colorectal adenocarcinoma HT-29 cell line. An increase of transcriptional levels of genes involved in serum resistance (aroE and traT) and adhesion (pgaA) was observed when compared with the Klebsiella quasipneumoniae subsp. similipneumoniae strain ATCC 700603 reference strain. Infection of G. mellonella larvae with ST392 clinical isolates showed that the latter were not highly pathogenic in this model. Together, our results indicate that ST392 isolates have the potential to become a strain of clinical relevance, especially in health settings where patients are immunosuppressed, e.g., transplant recipients.

Identifiants

pubmed: 32652494
pii: S0944-5013(20)30419-5
doi: 10.1016/j.micres.2020.126551
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
Bacterial Proteins 0
Polysaccharides, Bacterial 0
beta-Lactamases EC 3.5.2.6
beta-lactamase KPC-3, Klebsiella pneumoniae EC 3.5.2.6

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

126551

Informations de copyright

Copyright © 2020 Elsevier GmbH. All rights reserved.

Auteurs

Danilo D'Apolito (D)

Fondazione Ri.MED, Palermo, Italy; IRCCS-ISMETT, Palermo, Italy.

Fabio Arena (F)

Dipartimento di Medicina Clinica e Sperimentale, Università di Foggia, Foggia, Italy; IRCCS Fondazione Don Carlo Gnocchi, Milan, Italy.

Viola Conte (V)

Dipartimento di Biotecnologie Mediche, Università degli Studi di Siena, Siena, Italy.

Lucia Henrici De Angelis (LH)

Dipartimento di Biotecnologie Mediche, Università degli Studi di Siena, Siena, Italy.

Giuseppina Di Mento (G)

IRCCS-ISMETT, Palermo, Italy.

Anna Paola Carreca (AP)

Fondazione Ri.MED, Palermo, Italy.

Nicola Cuscino (N)

IRCCS-ISMETT, Palermo, Italy.

Giovanna Russelli (G)

IRCCS-ISMETT, Palermo, Italy.

Gioacchin Iannolo (G)

IRCCS-ISMETT, Palermo, Italy.

Floriana Barbera (F)

IRCCS-ISMETT, Palermo, Italy.

Salvatore Pasqua (S)

Fondazione Ri.MED, Palermo, Italy.

Francesco Monaco (F)

IRCCS-ISMETT, Palermo, Italy.

Francesca Cardinale (F)

IRCCS-ISMETT, Palermo, Italy.

Gian Maria Rossolini (GM)

Dipartimento di Medicina Sperimentale e Clinica, Università degli Studi di Firenze, Florence, Italy; SOD Microbiologia e Virologia, Azienda Ospedaliera Universitaria Careggi Florence, Italy.

Pier Giulio Conaldi (PG)

IRCCS-ISMETT, Palermo, Italy.

Bruno Douradinha (B)

Fondazione Ri.MED, Palermo, Italy; IRCCS-ISMETT, Palermo, Italy. Electronic address: bdouradinha@fondazionerimed.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH